The Day Hospital is a place where treatment meets compassion. 

Here, patients receive systemic treatments, namely chemotherapy, in an environment designed to promote comfort, privacy and reassurance.

Individual treatment booths allow family members to be present, creating moments of support throughout the care journey.

Nurses and doctors remain close at every step, carefully monitoring treatments, responding to patients’ needs and ensuring personalised and attentive care.

The Doctors’ Lounges are spaces where medicine continues beyond medical consultations and treatment rooms at the Champalimaud Foundation.

Here, doctors gather to review cases, exchange perspectives, update medical records, catch up on their reading and think together. 

It’s a place designed for concentration and care, where knowledge is constantly refined and expanded through everyday clinical practice.

It allows quiet moments to question and combine experience with research and study.

The Champalimaud Foundation today announced the acquisition of a portfolio of T-cell receptor (TCR) programs, platform technologies, and associated assets from Medigene Immunotherapies GmbH, together with the execution of an exclusive license agreement with Helmholtz Munich for key chimeric co-stimulatory receptor technologies.

[THIS CALL IS NOW CLOSED]

Offer Description

Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Operations Unit Officer fellow to join our team. 

Champalimaud Research (CR) has an open position for an Operations Unit Officer, to work in a professional, dynamic and diverse work environment at the Champalimaud Centre for the Unknown.

Caring for patients is one of the Champalimaud Foundation’s core purposes, and the Radiotherapy Service supports that mission every day. 

In a highly controlled environment, precise doses of radiation are targeted to treat different types of cancer. 

Behind this precision is a dedicated team of specialised doctors, physicists, nurses and technicians, working together to ensure each treatment is both safe and effective.

Every detail matters. Every decision is guided by expertise, responsibility and care.

A synergy in advanced therapies

Signed in Rome on 28 April, the agreement combines the Champalimaud Foundation’s expertise in adult oncology with Bambino Gesù’s recognised leadership in paediatric oncology and cell therapies. This synergy strengthens the link between research and clinical practice throughout the translational medicine pathway.

The symposium will bring together national and international experts to explore the dynamic evolution of the field, with a special focus on the close collaboration between radiology and surgery.

Diagnostic and interventional radiology are currently undergoing remarkable transformation. New imaging methodologies are redefining precision and diagnostic capability, achieving unprecedented levels of accuracy and clinical impact. Innovations such as photon-counting CT technology and ultra-fast MRI protocols are rapidly expanding the horizons of medical imaging.

Could radiotherapy become the standard for lung cancer treatment? Could Artificial Intelligence (AI) help oncologists in treatment selection? Should many more resources be devoted to prevention, namely populational screening for this cancer? 

Cancer experts gathered at the Champalimaud Foundation (CF), in Lisbon, for the third edition of the Lung Cancer Fight Club, to debate for a day on these and other issues.